Literature DB >> 19389752

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.

J Liang1, H Zhang, B Hua, H Wang, J Wang, Z Han, L Sun.   

Abstract

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system. Umbilical cord derived mesenchymal stem cells are immunosuppressive. We transplanted mesenchymal stem cells in a patient with refractory progressive MS, and the disease course was stabilized after the transplantation. We postulate that mesenchymal stem cells have a potent immunosuppressive effect in vivo.

Entities:  

Mesh：

Year:  2009        PMID： 19389752     DOI： 10.1177/1352458509104590

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  41 in total

Review 1.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

Review 2.  Regenerative therapy for neuronal diseases with transplantation of somatic stem cells.

Authors:  Hiroshi Kanno
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

3.  The survey on cellular and engineered tissue therapies in Europe in 2009.

Authors:  Ivan Martin; Helen Baldomero; Chiara Bocelli-Tyndall; Ineke Slaper-Cortenbach; Jakob Passweg; Alan Tyndall
Journal:  Tissue Eng Part A       Date:  2011-09       Impact factor: 3.845

4.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 5.  Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

Authors:  Nicolas Collongues; Laure Michel; Jérôme de Seze
Journal:  Curr Treat Options Neurol       Date:  2017-05       Impact factor: 3.598

Review 6.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 7.  Mesenchymal stem cell transplantation in multiple sclerosis.

Authors:  Jeffrey A Cohen
Journal:  J Neurol Sci       Date:  2013-01-04       Impact factor: 3.181

8.  Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Mamoru Uemura; Naotsugu Haraguchi; Junichi Nishimura; Taishi Hata; Chu Matsuda; Ichiro Takemasa; Masakazu Ikenaga; Kohei Murata; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2017-04-22       Impact factor: 3.199

9.  The Fas/Fap-1/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing.

Authors:  Xiaoxing Kou; Xingtian Xu; Chider Chen; Maria Laura Sanmillan; Tao Cai; Yanheng Zhou; Claudio Giraudo; Anh Le; Songtao Shi
Journal:  Sci Transl Med       Date:  2018-03-14       Impact factor: 17.956

10.  Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.

Authors:  Mollie Jurewicz; Sunmi Yang; Andrea Augello; Jonathan G Godwin; Robert F Moore; Jamil Azzi; Paolo Fiorina; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.